WHO rallies to equip new Ebola efforts in Congo:
This article was originally published in Clinica
Executive Summary
The World Health Organization (WHO) has confirmed that the Ebola virus is the cause of an outbreak of haemorrhagic fever (EHF) in the Republic of Congo. Two weeks since the first suspected case, more than 80 have been reported, including at least 64 deaths (at February 18), centred around the northwestern district of Kelle. The government is working with the WHO to co-ordinate measures aimed at monitoring and tackling the outbreak, in which testing plays an important part. EHF, one of the most virulent viral diseases, causing death in 50-90% of symptomatic cases, is transmitted by direct contact with the blood, body fluids and tissues of infected persons. This is the second outbreak to strike the region in 15 months.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.